Victoria Gray spent 34 years battling the debilitating pain of sickle cell disease. Then she volunteered to be the world's first "prototype" for a CRISPR therapy, based on technology invented at UC ...

In this GEN webinar, our expert speakers will show how Nanoworx combines technical expertise with scalable workflows to support the seamless development of nanomedicines from early discovery and ...

IDH-mutant glioma, caused by abnormalities in a specific gene (IDH), is the most common malignant brain tumor among young adults under the age of 50 ...

Non-dilutive public-private funded trial with NIAID STTR & Mary Gooze Clinical Trial and Translation AwardExpands iNKT platform into ...

For the first time, researchers at the University of British Columbia have demonstrated how to reliably produce an important type of human immune cell—known as helper T cells—from stem cells in a ...

CS-101 is Shanghai-based CorrectSequence's lead candidate, which it is developing for treating sickle-cell disease and ...

Illumina, whose EMEA head office is at Granta Park in Cambridge, has released Illumina Connected Multiomics, a powerful cloud ...

Researchers developed two computational tools to decode how cells communicate in tissues. sCCIgen creates realistic virtual ...

The "In Situ Hybridization Market Report by Product, Technique, Application, End User, Countries and Company Analysis ...

CareDx Inc. has entered a strategic collaboration with 10x Genomics to establish ImmuneScape, a multiomics research ...

The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercialization ...

Illumina, Inc. today announced the release of Illumina Connected Multiomics, a powerful cloud-based research software ...